Zacks Investment Research | Oct 12, 2017 08:48AM ET
Henry Schein, Inc. (NASDAQ:HSIC) recently completed the earlier announced buyout of Merritt Veterinary Supplies under certain undisclosed financial terms. With this, Merritt will be part of the veterinary business of Henry Schein, namely, Henry Schein Animal Health.
Merritt is an independent, family-owned supplier of animal health products. Merritt has 4,500 veterinary clinics across the eastern United States, with a strong presence in the southeastern part of the nation. The company offers a comprehensive line of products, including pharmaceuticals, diagnostics and equipment. Merritt generated revenues of approximately $115 million in 2016.
According to Henry Schein, this acquisition will drive earnings per share after 2017.
Henry Schein has been consistently trying to expand its Animal Health business. The company’s global Animal Health segment witnessed 4.4% improvement in revenues in the last reported second quarter. Recently, Henry Schein Animal Health announced the opening of a new National Distribution Service Center in Columbus' Brookhollow neighborhood, expanding its presence in central Ohio.
At the beginning of 2017, Henry Schein had entered the Brazilian animal health market with a 51% investment in Tecnew, a privately held distributor of animal health products. Prior to that, the company had acquired RxWorks, a leading provider of veterinary practice management software, primarily to customers in Australia, New Zealand, the U.K., the Netherlands and other countries.
According to a report by Grand View Research, the global animal health market is expected to reach a value of $58.4 billion by 2025. Considering the huge potential of the market, we believe the latest development is strategic.
Over the past year, Henry Schein has underperformed the broader Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.